• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病中活化部分凝血活酶时间水平与冠状动脉病变:一项回顾性队列研究。

Activated partial thromboplastin time levels and coronary artery lesions in Kawasaki disease: A retrospective cohort study.

作者信息

Zhou Jinhui, Ni Chao, Wang Zhenquan, Xia Yuhan, Shi Hongying, Zhao Xiaoshan, Chen Yufei, Liu Chenchen, Rong Xing, Wu Rongzhou, Chu Maoping, Qiu Huixian

机构信息

Children's Heart Center, The Second Affiliated Hospital and Yuying Children's Hospital, Institute of Cardiovascular Development and Translational Medicine, Wenzhou Medical University, Wenzhou 325000, Zhejiang, China; Zhejiang Provincial Clinical Research Center for Pediatric Disease, Wenzhou Medical University, Zhejiang, China.

Institute of Aging, Key Laboratory of Alzheimer's Disease of Zhejiang Province, Zhejiang Provincial Clinical Research Center for Mental Disorders, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.

出版信息

Microvasc Res. 2025 Jul;160:104817. doi: 10.1016/j.mvr.2025.104817. Epub 2025 May 7.

DOI:10.1016/j.mvr.2025.104817
PMID:40345320
Abstract

OBJECTIVE

Kawasaki disease (KD) is an acute systemic inflammation, that affects medium-sized arteries. Coronary artery lesions (CALs) were the most serious complication or sequelae of KD. The intense inflammatory response leads to platelet activation, further exacerbating inflammation, which plays an important role in the pathogenesis of CALs in KD patients. Plus, coagulation factors are closely related to platelet activation. Therefore, we speculate that the activated partial thromboplastin time (APTT), an indicator of coagulation factor function, may be involved in the occurrence of CALs, but it has not been explored yet. This study aims to investigate the effect of the APTT level on CALs occurrence in the acute phase of KD.

METHODS

A total of 2303 KD patients during a 10-year period were recruited at the Wenzhou Medical University affiliated Yuying Children's Hospital. A total of 1715 patients who completed the follow-up were enrolled in the final analysis and were divided into the low APTT group and the high APTT group at a 46 s cutoff before receiving intravenous immunoglobulin (IVIG) treatment. Multiple logistic regression analysis and stratified analysis were utilized to evaluate the independent impact of APTT levels on the occurrence of CALs and to determine the impact of APTT levels on the occurrence of CALs in different subgroups, respectively.

RESULTS

The incidence of CALs in the low APTT group and the high APTT group was 12.5 % and 17.5 %, respectively (P = 0.005). Patients with high APTT levels had higher CRP levels (P < 0.001). High APTT levels were the independent risk factor on the occurrence of CALs; the adjusted odds ratio (OR) was 1.523 (95 % CI: 1.144, 2.028). Similar results were found in stratification analysis and sensitivity analysis.

CONCLUSIONS

KD patients with high APTT levels (≥46 s) before IVIG treatment may be more prone to developing CALs in the acute phase of KD.

摘要

目的

川崎病(KD)是一种影响中等大小动脉的急性全身性炎症。冠状动脉病变(CALs)是KD最严重的并发症或后遗症。强烈的炎症反应导致血小板活化,进一步加剧炎症,这在KD患者CALs的发病机制中起重要作用。此外,凝血因子与血小板活化密切相关。因此,我们推测活化部分凝血活酶时间(APTT),一种凝血因子功能指标,可能参与CALs的发生,但尚未进行过探索。本研究旨在探讨APTT水平对KD急性期CALs发生的影响。

方法

在温州医科大学附属育英儿童医院招募了10年间共2303例KD患者。共有1715例完成随访的患者纳入最终分析,并在接受静脉注射免疫球蛋白(IVIG)治疗前以46秒为界分为低APTT组和高APTT组。采用多因素logistic回归分析和分层分析分别评估APTT水平对CALs发生的独立影响以及APTT水平对不同亚组CALs发生的影响。

结果

低APTT组和高APTT组CALs的发生率分别为12.5%和17.5%(P = 0.005)。APTT水平高的患者CRP水平更高(P < 0.001)。高APTT水平是CALs发生的独立危险因素;调整后的比值比(OR)为1.523(95%CI:1.144,2.028)。在分层分析和敏感性分析中发现了类似结果。

结论

IVIG治疗前APTT水平高(≥46秒)的KD患者在KD急性期可能更容易发生CALs。

相似文献

1
Activated partial thromboplastin time levels and coronary artery lesions in Kawasaki disease: A retrospective cohort study.川崎病中活化部分凝血活酶时间水平与冠状动脉病变:一项回顾性队列研究。
Microvasc Res. 2025 Jul;160:104817. doi: 10.1016/j.mvr.2025.104817. Epub 2025 May 7.
2
The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.血清脂质在预测川崎病冠状动脉病变和静脉注射免疫球蛋白抵抗中的作用:一项队列研究。
J Int Med Res. 2024 May;52(5):3000605241252115. doi: 10.1177/03000605241252115.
3
A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.一项前瞻性研究比较了川崎病患者血清 IL6 和 CRP 水平与冠状动脉变化和治疗反应的关系。
Rheumatol Int. 2019 Oct;39(10):1797-1801. doi: 10.1007/s00296-019-04375-9. Epub 2019 Jul 13.
4
Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.单核细胞/高密度脂蛋白胆固醇比值对川崎病冠状动脉病变及静脉用免疫球蛋白抵抗的预测价值。
Eur J Pediatr. 2023 Oct;182(10):4399-4406. doi: 10.1007/s00431-023-05122-w. Epub 2023 Jul 22.
5
Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.延迟静脉注射免疫球蛋白治疗增加了不同状态川崎病患儿冠状动脉病变的风险。
Postgrad Med. 2018 May;130(4):442-447. doi: 10.1080/00325481.2018.1468712. Epub 2018 May 10.
6
Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.血清脂质对川崎病静脉免疫球蛋白抵抗和冠状动脉病变的预测价值。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4210-e4220. doi: 10.1210/clinem/dgab230.
7
A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?川崎病急性期静脉注射免疫球蛋白治疗的回顾性队列研究:是否越早越好?
Cardiovasc Ther. 2021 Jun 18;2021:6660407. doi: 10.1155/2021/6660407. eCollection 2021.
8
Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?英夫利昔单抗联合静脉注射免疫球蛋白(IVIG)与单独 IVIG 作为有冠状动脉损伤的川崎病患儿初始治疗的比较:双治疗更有效吗?
Pediatr Infect Dis J. 2018 Oct;37(10):976-980. doi: 10.1097/INF.0000000000001951.
9
Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.临床指标联合 S100A12/TLR2 信号分子建立川崎病冠状动脉病变新的评分模型。
PLoS One. 2023 Oct 12;18(10):e0292653. doi: 10.1371/journal.pone.0292653. eCollection 2023.
10
Diagnostic value of syndecan-1 for coronary artery lesions and correlation analysis of laboratory indicators in Kawasaki disease patients.血清透明质酸酶-1 对川崎病患者冠状动脉病变的诊断价值及实验室指标的相关性分析。
Ital J Pediatr. 2024 Oct 9;50(1):209. doi: 10.1186/s13052-024-01772-0.